HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DIAGENS-B

529.000

+39.2008.00%

Volume:45.41K

Turnover:23.13M

Market Cap:47.02B

PE:-630.49

High:540.000

Open:488.200

Low:463.000

Close:489.800

52wk High:765.500

52wk Low:178.000

Shares:88.88M

HK Float Shares:88.88M

Volume Ratio:0.58

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.839

ROE:-39.50%

ROA:-23.53%

PB:51.99

PE(LYR):-630.49

PS:219.83

Loading ...

Overview Company News Filings

Hangzhou Diagens Biotech Schedules Board Meeting to Review Interim Results, Consider Dividend

Hangzhou Diagens Biotechnology Held Extraordinary General Meeting; 77.78% of Shares Voted

Diagnostic Imaging Specialist DIAGENS-B Surges Over 11% Following Strategic AI Partnership and iMedLoop™ Platform Launch

Diagens Plans to Broaden Business Scope to AI, Big Data and Telecom Services; Seeks Shareholder Approval on 23 July 2026

Bulletin Express

Hangzhou Diagens Proposes Bylaw Amendments Expanding Business Scope into AI and Data Services

Diagens Schedules 2026 First EGM for 23 July to Approve Business Scope Adjustment and Articles Amendment

Bulletin Express

Diagens Proposes Business Scope Expansion, Seeks Shareholder Nod at 23 July EGM

Bulletin Express

Hangzhou Diagens Biotechnology Announces Extraordinary General Meeting

DIAGENS-B Surges Over 9% to Record High as iMedLoop Platform Establishes Comprehensive Closed-Loop Foundation, Reinforcing Core Medical AI Competitive Logic

Diagnostic Imaging AI Firm DIAGENS-B Surges Over 13% on Launch of iMedLoop Global Medical Imaging Data Platform

DIAGENS-B (02526) Builds iMedLoop as a Productivity Foundation, Unlocking Platform-Level Valuation Premium for Medical AI

DIAGENS-B Unveils iMedLoop, Paving the Way for Industrial-Scale AI in Medical Imaging

Diagens Biotechnology Sets Book Closure Window Ahead of 23 July 2026 EGM

Bulletin Express

Hangzhou Diagens Biotechnology Announces Extraordinary General Meeting

Hangzhou Diagens Biotech Shareholders Approved 2025 Annual Report at AGM

Hangzhou Diagens Biotechnology announces annual general meeting

Stock Track | DIAGENS-B Soars 22.29% in Morning Session After Securing World-First Medical AI Certification

DIAGENS-B (02526) Surges Over 22% to New High as Core AI Product Secures Landmark Medical Imaging Certification

World's First Medical Imaging AI Secures Top-Level Regulatory Approval: DIAGENS-B's AI AutoVision® Strengthens Technological Moat

Diagens Biotechnology's Chromosome Analysis Device Gets Registration Certificate in China

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/02526/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02526","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02526\",,,,,undefined,":{"symbol":"02526","market":"HK","secType":"STK","nameCN":"DIAGENS-B","latestPrice":529,"timestamp":1788163726622,"preClose":489.8,"halted":0,"volume":45405,"delay":0,"changeRate":0.08003266639444669,"floatShares":88879200,"shares":88879200,"eps":-0.839024,"marketStatus":"Not Yet Opened","change":39.2,"latestTime":"08-31 16:08:46","open":488.2,"high":540,"low":463,"amount":23129735,"amplitude":0.157207,"askPrice":540,"askSize":150,"bidPrice":529,"bidSize":150,"shortable":0,"etf":0,"ttmEps":-1.576,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":0,"adr":0,"listingDate":1774800000000,"exchange":"SEHK","adjPreClose":489.8,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"volumeRatio":0.5807231381918635,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02526\",,,,,undefined,":{"symbol":"02526","floatShares":88879200,"roa":"-23.53%","roe":"-39.50%","lyrEps":-0.839024,"volumeRatio":0.5807231381918635,"shares":88879200,"dividePrice":0,"high":540,"amplitude":0.157207,"preClose":489.8,"low":463,"week52Low":178,"pbRate":"51.99","psRate":"219.83","week52High":765.5,"institutionHeld":0,"latestPrice":529,"eps":-0.839024,"divideRate":0,"volume":45405,"delay":0,"ttmEps":-1.576,"open":488.2,"prevYearClose":99,"prevWeekClose":489.8,"prevMonthClose":529,"prevQuarterClose":309.8,"fiveDayClose":723,"twentyDayClose":387.4,"sixtyDayClose":320.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02526\",params:#limit:5,,,undefined,":[{"date":"2026-08-07","symbol":"02526","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786066200000,"name":null,"time":"","dateTimestamp":1786032000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02526\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02526\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02526\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02526","date":"2026-08-28","current":-335.659898,"percent":0.861386,"low":-545.299386,"twenty":-400.612159,"median":-352.216988,"eighty":-315.707365,"high":-208.205701,"avg":-356.577672,"sd":65.687493,"marketCap":43533032160},"quantilePoints":[{"date":"2026-04-02","current":-272.27881,"twenty":-277.682472,"median":-258.576907,"eighty":-239.167269,"marketCap":20797732800},{"date":"2026-04-10","current":-346.403686,"twenty":-339.232012,"median":-285.787965,"eighty":-250.355764,"marketCap":26663760000},{"date":"2026-04-17","current":-325.713634,"twenty":-334.091876,"median":-317.126763,"eighty":-274.980641,"marketCap":25081710240},{"date":"2026-04-24","current":-330.080861,"twenty":-335.567541,"median":-326.636989,"eighty":-290.709378,"marketCap":25419451200},{"date":"2026-04-30","current":-332.18176,"twenty":-334.015312,"median":-325.713634,"eighty":-310.395031,"marketCap":25597209600},{"date":"2026-05-08","current":-379.447849,"twenty":-346.403686,"median":-328.46508,"eighty":-310.958904,"marketCap":29330136000},{"date":"2026-05-15","current":-344.735778,"twenty":-356.513965,"median":-332.396872,"eighty":-313.054502,"marketCap":26717087520},{"date":"2026-05-22","current":-402.3084,"twenty":-358.871836,"median":-336.827112,"eighty":-315.164028,"marketCap":31107720000},{"date":"2026-05-29","current":-406.641648,"twenty":-379.946058,"median":-343.048303,"eighty":-318.304405,"marketCap":31552116000},{"date":"2026-06-05","current":-360.299962,"twenty":-379.450143,"median":-344.735778,"eighty":-319.954129,"marketCap":27996948000},{"date":"2026-06-12","current":-372.447501,"twenty":-375.674905,"median":-349.027955,"eighty":-324.604965,"marketCap":28921291680},{"date":"2026-06-18","current":-353.616435,"twenty":-376.618141,"median":-353.630358,"eighty":-326.267647,"marketCap":27517000320},{"date":"2026-06-26","current":-343.086832,"twenty":-373.551497,"median":-351.652224,"eighty":-326.764376,"marketCap":26574880800},{"date":"2026-07-03","current":-355.442852,"twenty":-372.637829,"median":-352.781753,"eighty":-328.141924,"marketCap":27552552000},{"date":"2026-07-10","current":-525.783409,"twenty":-380.947063,"median":-353.887402,"eighty":-330.921221,"marketCap":40706673600},{"date":"2026-07-17","current":-330.366333,"twenty":-387.12216,"median":-355.442852,"eighty":-331.092504,"marketCap":25668312960},{"date":"2026-07-24","current":-307.647435,"twenty":-382.392854,"median":-353.630358,"eighty":-326.721913,"marketCap":23908504800},{"date":"2026-07-31","current":-369.618431,"twenty":-381.442978,"median":-353.199094,"eighty":-325.898305,"marketCap":28779084960},{"date":"2026-08-07","current":-476.223264,"twenty":-396.494596,"median":-354.130521,"eighty":-326.679451,"marketCap":37151505600},{"date":"2026-08-14","current":-232.289361,"twenty":-400.612159,"median":-353.887402,"eighty":-323.520825,"marketCap":32885304000},{"date":"2026-08-21","current":-329.499393,"twenty":-396.494596,"median":-352.781753,"eighty":-318.122472,"marketCap":46750459200},{"date":"2026-08-28","current":-306.753265,"twenty":-400.612159,"median":-352.216988,"eighty":-315.707365,"marketCap":43533032160}],"updateTime":1788209303140},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02526\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654072988","title":"Hangzhou Diagens Biotech Schedules Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2654072988","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654072988?lang=en_us&edition=fundamental","pubTime":"2026-07-28 16:30","pubTimestamp":1785227456,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotech schedules board meeting to review interim results, consider dividendHangzhou Diagens Biotechnology schedules a board meeting for Aug. 7, 2026 to review interim results for the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDLl3T6s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653274586","title":"Hangzhou Diagens Biotechnology Held Extraordinary General Meeting; 77.78% of Shares Voted","url":"https://stock-news.laohu8.com/highlight/detail?id=2653274586","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653274586?lang=en_us&edition=fundamental","pubTime":"2026-07-23 17:47","pubTimestamp":1784800069,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology held extraordinary general meeting; 77.78% of shares votedHangzhou Diagens Biotechnology held its first extraordinary general meeting on July 23, 2026.Shareholders adopt","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL4fZBsb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154235801","title":"Diagnostic Imaging Specialist DIAGENS-B Surges Over 11% Following Strategic AI Partnership and iMedLoop™ Platform Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=1154235801","media":"Stock News","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154235801?lang=en_us&edition=fundamental","pubTime":"2026-07-21 11:26","pubTimestamp":1784604413,"startTime":"0","endTime":"0","summary":"Shares of DIAGENS-B (ASX: 02526) have surged more than 11%. At the time of reporting, the stock was up 10.5% to HK$299, with a trading turnover of HK$11.89 million.The price movement follows the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4585","BK1100","BK4588","03396","KCAI","02526","BK1607","BK1193"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115564884","title":"Diagens Plans to Broaden Business Scope to AI, Big Data and Telecom Services; Seeks Shareholder Approval on 23 July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1115564884","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115564884?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:24","pubTimestamp":1783423487,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (Diagens, 02526) has announced a proposal to expand its business scope significantly beyond its existing biochemical R&D and medical-device activities. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984338","title":"Hangzhou Diagens Proposes Bylaw Amendments Expanding Business Scope into AI and Data Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984338","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649984338?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:06","pubTimestamp":1783422413,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens proposes bylaw amendments expanding business scope into AI and data servicesHangzhou Diagens proposed bylaw changes to expand its registered business scope into software, data service","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDLblKJcc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182654157","title":"Diagens Schedules 2026 First EGM for 23 July to Approve Business Scope Adjustment and Articles Amendment","url":"https://stock-news.laohu8.com/highlight/detail?id=1182654157","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182654157?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:04","pubTimestamp":1783422248,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (Diagens) will convene its 2026 first extraordinary general meeting (EGM) at 2:00 p.m. on Thursday, 23 July 2026 in Conference Room 1, 9th Floor, Building A,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190344080","title":"Diagens Proposes Business Scope Expansion, Seeks Shareholder Nod at 23 July EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1190344080","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190344080?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:03","pubTimestamp":1783422237,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (“Diagens”) has called its first extraordinary general meeting (EGM) of 2026 for 14:00 on 23 July 2026 in Hangzhou to secure shareholder approval for two key...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649981908","title":"Hangzhou Diagens Biotechnology Announces Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2649981908","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649981908?lang=en_us&edition=fundamental","pubTime":"2026-07-07 18:41","pubTimestamp":1783420917,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology announces extraordinary general meetingHangzhou Diagens Biotechnology will hold an extraordinary general meeting in Hangzhou, China on July 23, 2026.Shareholders will vo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL57PnNy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162540174","title":"DIAGENS-B Surges Over 9% to Record High as iMedLoop Platform Establishes Comprehensive Closed-Loop Foundation, Reinforcing Core Medical AI Competitive Logic","url":"https://stock-news.laohu8.com/highlight/detail?id=1162540174","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162540174?lang=en_us&edition=fundamental","pubTime":"2026-07-07 10:10","pubTimestamp":1783390227,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) shares have surged over 9% again, reaching an intraday high of HK$440, setting a new record since its listing. As of writing, the stock is up 8.37% to HK$432.4, with a turnover of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","VXUS","150261","KCAI","02526","BK4588","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154921942","title":"Diagnostic Imaging AI Firm DIAGENS-B Surges Over 13% on Launch of iMedLoop Global Medical Imaging Data Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1154921942","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154921942?lang=en_us&edition=fundamental","pubTime":"2026-07-06 09:40","pubTimestamp":1783302030,"startTime":"0","endTime":"0","summary":"Shares of DIAGENS-B (ASX: 02526) surged more than 13% during the morning trading session. At the time of writing, the stock was up 8.58%, trading at HK$336.6 with a turnover of HK$2.4756 million. The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159891","VXUS","BK4588","KCAI","02526","BK4585","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102062229","title":"DIAGENS-B (02526) Builds iMedLoop as a Productivity Foundation, Unlocking Platform-Level Valuation Premium for Medical AI","url":"https://stock-news.laohu8.com/highlight/detail?id=1102062229","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102062229?lang=en_us&edition=fundamental","pubTime":"2026-07-06 09:13","pubTimestamp":1783300403,"startTime":"0","endTime":"0","summary":"The capital frenzy around general-purpose large models is gradually becoming more rational, with the market urgently seeking the next wave of hard technology growth curves. Against this macro...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["150261","BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157528887","title":"DIAGENS-B Unveils iMedLoop, Paving the Way for Industrial-Scale AI in Medical Imaging","url":"https://stock-news.laohu8.com/highlight/detail?id=1157528887","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157528887?lang=en_us&edition=fundamental","pubTime":"2026-07-05 16:34","pubTimestamp":1783240491,"startTime":"0","endTime":"0","summary":"The structural imbalance of high-quality medical resources represents the most challenging supply-side issue in the current healthcare system. Top-tier hospitals are overcrowded, while primary care...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","BK1100","QTOC","VTHR","AIPO","02526","AGIX","159891","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161913779","title":"Diagens Biotechnology Sets Book Closure Window Ahead of 23 July 2026 EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1161913779","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161913779?lang=en_us&edition=fundamental","pubTime":"2026-07-03 19:25","pubTimestamp":1783077942,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) will convene an extraordinary general meeting (EGM) on Thursday, 23 July 2026. The company will close its register of members from Monday, 20 July...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648166345","title":"Hangzhou Diagens Biotechnology Announces Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2648166345","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648166345?lang=en_us&edition=fundamental","pubTime":"2026-07-03 19:06","pubTimestamp":1783076810,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology announces extraordinary general meetingHangzhou Diagens Biotechnology will hold an extraordinary general meeting in Hong Kong on July 23, 2026.The company plans to publi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nNDL1hjSLr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646356421","title":"Hangzhou Diagens Biotech Shareholders Approved 2025 Annual Report at AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2646356421","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646356421?lang=en_us&edition=fundamental","pubTime":"2026-06-26 18:19","pubTimestamp":1782469169,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotech shareholders approved 2025 annual report at AGMHangzhou Diagens Biotechnology held its 2025 annual general meeting on June 26, 2026.Shareholders adopted the annual report, app","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL4KjnY4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640090163","title":"Hangzhou Diagens Biotechnology announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640090163","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640090163?lang=en_us&edition=fundamental","pubTime":"2026-06-04 22:36","pubTimestamp":1780583816,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology will hold its 2025 annual general meeting in Hangzhou on June 26, 2026.Shareholders will vote on the 2025 annual report, profit distribution plan, annual financial report, 2026 budget, auditor reappointment, director pay package, independent director confirmations.Meeting also seeks mandates to issue up to 20% new shares, repurchase up to 10% of H shares, amend the articles of association.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Diagens Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDLZCQCc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172628570","title":"Stock Track | DIAGENS-B Soars 22.29% in Morning Session After Securing World-First Medical AI Certification","url":"https://stock-news.laohu8.com/highlight/detail?id=1172628570","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172628570?lang=en_us&edition=fundamental","pubTime":"2026-05-26 10:00","pubTimestamp":1779760850,"startTime":"0","endTime":"0","summary":"DIAGENS-B's stock price surged 22.29% during the morning trading session on Tuesday, marking a significant upward movement for the healthcare technology company.The sharp increase followed the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181499976","title":"DIAGENS-B (02526) Surges Over 22% to New High as Core AI Product Secures Landmark Medical Imaging Certification","url":"https://stock-news.laohu8.com/highlight/detail?id=1181499976","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181499976?lang=en_us&edition=fundamental","pubTime":"2026-05-26 09:50","pubTimestamp":1779760249,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) surged more than 22% in morning trading, reaching a high of HK$428 and setting a new record high since its listing. As of the time of writing, the stock was up 17.43% to HK$411,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251","CHAT","BK1189","VXUS","AIPO","02526","BK4588","ARTY","AGIX","BK4585","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104465492","title":"World's First Medical Imaging AI Secures Top-Level Regulatory Approval: DIAGENS-B's AI AutoVision® Strengthens Technological Moat","url":"https://stock-news.laohu8.com/highlight/detail?id=1104465492","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104465492?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:21","pubTimestamp":1779452465,"startTime":"0","endTime":"0","summary":"On May 22, DIAGENS-B (02526) announced that its self-developed AI AutoVision® Chromosome Karyotype Assisted Diagnostic Software has officially obtained the Class III Medical Device Registration...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251","AIPO","AGIX","ARTY","CHAT","02526","BK1100","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637319943","title":"Diagens Biotechnology's Chromosome Analysis Device Gets Registration Certificate in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2637319943","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637319943?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:40","pubTimestamp":1779450012,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology's  AI AutoVision core product obtained a Class III Medical Device Registration Certificate from China's National Medical Products Administration.The approved indications under the certificate cover chromosome karyotype analysis for prenatal diagnosis of birth defects using amniotic fluid samples and assisted reproduction using peripheral blood samples, according to a Friday filing with the Hong Kong bourse.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":88,"code":"91000000","status":"200"}]}}